Skip to main content
SpringerLink
Log in
Book cover

Management of Benign Prostatic Hypertrophy pp 163–193Cite as

Transurethral Resection of the Prostate

  • Chapter

  • 224 Accesses

Part of the book series: Current Clinical Urology ((CCU))

Abstract

Benign prostatic hyperplasia (BPH) causes a multitude of urinary symptoms as a result of obstruction of the bladder outlet. There are many phytotherapeutic and pharmacologic agents to treat BPH. BPH is more likely to be managed initially by primary care physicians and internists (49% of cases) than by urologists (37%) (1). Furthermore, minimally invasive techniques such as transurethral microwave hyperthermia (TUMT), transurethral needle ablation (TUNA), water-induced thermotherapy (WIT), and interstitial laser therapy have expanded the treatment options for BPH. Nevertheless, transurethral resection of the prostate (TURP) continues to be the mainstay of therapy and the gold standard surgical technique. In the United States, approx 25% of men are treated for BPH by the age of 80 yr, and more than 300,000 surgical procedures are performed annually for BPH. TURP is the second most commonly performed surgical procedure, at a cost estimated to be $2 billion (2). Despite the availability of pharmacotherapy and minimally invasive options, TURP remains a popular treatment for BPH because of its familiarity among urologists and superiority in treating the symptoms of prostatism, particularly urinary retention.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bruskewitz R. Medical management of BPH in the US. Eur Urol 1999; 36 (suppl 3): 7–13.

    Article  PubMed  Google Scholar 

  2. McConnell JD, Barry MJ, Bruskewitz RC, et al. Benign Prostatic Hyperplasia: Diagnosis and Treatment; Clinical Practice Guideline Number 8. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Rockville, Maryland, 1994.

    Google Scholar 

  3. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, and Writing Committee. Transurethral prostatectomy immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243–247.

    PubMed  CAS  Google Scholar 

  4. Barry MJ, Fowler FJ, O’ Leary MP, et al. The American Urological Association’ s symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–1557.

    PubMed  CAS  Google Scholar 

  5. Oesterling JE. Retropubic and suprapubic prostatectomy. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein Ai, eds., Campbell’s Urology, ed. 7, vol 2, Philadelphia: WB Saunders, 1998, p. 1529.

    Google Scholar 

  6. Sinha B, Haikel G, Lange PH, Moon TD, Narayan P. Transurethral resection of the prostate with local anesthesia in 100 patients. J Urol 1986: 135: 719–721.

    PubMed  CAS  Google Scholar 

  7. Birch BR, Gelister JS, Parker CJ, Chave H, Miller RA. Transurethral resection of prostate under sedation and local anesthesia (sedoanalgesia). Experience in 100 patients. Urology 1991; 38: 113–118.

    Article  PubMed  CAS  Google Scholar 

  8. Chander J, Gupta U, Mehra R, Ramteke VK. Safety and efficacy of transurethral resection of the prostate under sedoanalgesia. BJU Int 2000; 86: 220–222.

    Article  PubMed  CAS  Google Scholar 

  9. Malhotra V. Transurethral resection of the prostate. Anesth Clin N Am 2000; 18: 883–897.

    Article  CAS  Google Scholar 

  10. Neilsen KK, Andersen K, Asbjorn J, Vork F, Ohr-Nissen A. Blood loss during transurethral prostatectomy: epidural versus general anesthesia. Int Urol Nephrol 1987; 19: 287–292.

    Article  Google Scholar 

  11. Madsen P, Larsen E, Dorflinger T. The role of antibacterial prophylaxis in urological surgery. Urology 1985; 26: 38–42.

    PubMed  CAS  Google Scholar 

  12. McEntee GP, McPhail S, Mulvin D, Thomson RW. Single dose antibiotic prophylaxis in high risk patients undergoing transurethral prostatectomy. Br J Surg 1987; 74: 192–194.

    Article  PubMed  CAS  Google Scholar 

  13. Gibbons RP, Stark RA, Correa RI, Cummings KB, Mason JT. The prophylactic use-or misuse-of antibiotics in transurethral prostatectomy. J Urol 1978; 119: 381–383.

    PubMed  CAS  Google Scholar 

  14. Berry A, Barratt A. Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis. J Urol 2002; 167: 571–577.

    Article  PubMed  Google Scholar 

  15. Blandy JP, Notley RG. Transurethral Resection of the Prostate, 3rd ed, Oxford, UK: Butterworth- Heinemann, 1993, p. 52–104.

    Google Scholar 

  16. Richter S, Ringel A, Sluzker D. Combined cystolithotomy and transurethral resection of prostate: best management of infravesical obstruction and massive or multiple bladder stones. Urology 2002; 59: 688–691.

    Article  PubMed  Google Scholar 

  17. Creevy CD. Hemolytic reactions during transurethral prostatic resection. J Urol 1947; 58: 125–131.

    PubMed  CAS  Google Scholar 

  18. Creevy CD, Webb EA. A fatal hemolytic reaction following transurethral resection of the prostate gland: a discussion of its prevention and treatment. Surgery 1947; 21: 56–66.

    PubMed  CAS  Google Scholar 

  19. Beirne GJ, Madsen PO, Burns RO. Serum electrolyte and osmolality changes following transurethral resection of the prostate. J Urol 1954; 93: 83–86.

    Google Scholar 

  20. Holtgrewe H, Valk W. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 1962; 87: 450–459.

    PubMed  CAS  Google Scholar 

  21. Borboroglu PG, Prodromos G, Kane C, et al. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999; 162: 1307–1310.

    Article  PubMed  CAS  Google Scholar 

  22. Roos NP, Wennberg JE, Malenka DJ, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 320: 1120–1124.

    Article  PubMed  CAS  Google Scholar 

  23. Chute CG, Stephenson WP, Guess HA, Lieber M. Benign prostatic hyperplasia: a population based study. Eur Urol 1991; 20 (suppl 1): 11–17.

    PubMed  Google Scholar 

  24. Fuglsig S, Aagaard K, Jonler M, Olesen S, Norgaard JP. Survival after transurethral resection of the prostate: a 10-year follow-up. J Urol 1994; 151: 637–639.

    PubMed  CAS  Google Scholar 

  25. Kearney MC, Bingham JB, Bergland R, Meade-D’Alisera P, Puchner PJ. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia. J Urol 2002; 167: 2489–2491.

    Article  PubMed  CAS  Google Scholar 

  26. Hirshberg E, Klotz L. Post transurethral resection of prostate incontinence in previously radiated prostate cancer patients. Can J Urol 1998; 5 (2): 560–563.

    PubMed  Google Scholar 

  27. Soderdahl DW, Knight RW, Hansberry KL. Erectile dysfunction following transurethral resection of the prostate. J Urol 1996; 156: 1354–1356.

    Article  PubMed  CAS  Google Scholar 

  28. Bieri S, Iselin C, Rohner S. Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunction after transurethral prostatectomy. Scand J Urol Nephrol 1997; 31: 545–548.

    Article  PubMed  CAS  Google Scholar 

  29. Perera N, Hill J. Erectile and ejaculatory failure after transurethral prostatectomy. Ceylon Med J 1998; 43: 74–77.

    PubMed  CAS  Google Scholar 

  30. Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on transurethral resection of the prostate. N Engl J Med 1995; 332: 75–79.

    Article  PubMed  CAS  Google Scholar 

  31. Brookes ST, Donovan JL, Peters TJ, Abrams P, Neal DE. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomized controlled trial. BMJ 2002; 324: 1059–1061.

    Article  PubMed  Google Scholar 

  32. Flanigan RC, Reda DC, Wasson JH, et al. Five year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans’ Affairs cooperative study. J Urol 1998; 160: 12–16.

    Article  PubMed  CAS  Google Scholar 

  33. Riehmann M, Knes JM, Heisey D, Madsen PO, Bruskewitz RC. Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology 1995; 45: 76–775.

    Article  Google Scholar 

  34. Yang Q, Peter TJ, Donovan JL, Wilt TJ, Abrams P. Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: a systematic review and meta-analysis of randomized controlled trials. J Urol 2001; 165: 1526–1532.

    Article  PubMed  CAS  Google Scholar 

  35. Donovan JL, Peters TJ, Neal DE, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: the CLasP study. J Urol 2000; 164: 65–70.

    Article  PubMed  CAS  Google Scholar 

  36. Gujral S, Abrams P, Donovan JL, et al. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol 2000; 164: 59–64.

    Article  PubMed  CAS  Google Scholar 

  37. Chacko KN, Donovan JL, Abrams P, et al. Transurethral prostatic resection or laser therapy for men with acute urinary retention: the ClasP randomized trial. J Urol 2000; 164: 166–170.

    Article  Google Scholar 

Download references

Authors
  1. Harris E. Foster Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Micah Jacobs BA
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Kevin T. McVary MD, FACS

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Foster, H.E., Jacobs, M. (2004). Transurethral Resection of the Prostate. In: McVary, K.T. (eds) Management of Benign Prostatic Hypertrophy. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-644-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-644-7_11

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9806-6

  • Online ISBN: 978-1-59259-644-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation